Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma

Journal of Cardiovascular Magnetic Resonance

Volumn 8, Issue 6, 2006, Pages 789-791

  Perel, Robert D ^a   Slaughter, Richard E ^a   Strugnell, Wendy E ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Anthracycline; Cardiotoxicity; CMR; Ewing's sarcoma; Late gadolinium enhancement

Indexed keywords

ANTHRACYCLINE; GADOLINIUM;

ADULT; ANAMNESIS; ARTICLE; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAM; EWING SARCOMA; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; BONE NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIUM; SARCOMA, EWING'S;

EID: 33750301433     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1080/10976640600737664     Document Type: Article

References (8)

1. Meinardi MT, van der Graaf WT, van Veldhuisen DJ, Gietema JA, de Vries EG, Sleijfer DT. Detection of anthracycline-induced cardiotoxicity. Cancer Treat Rev 1999;25:237-47.
2. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998;339:900-5.
3. Pein F, Sakiroglu O, Dahan M, Lebidois J, Merlet P, Shamsaldin A, Villain E, de Vathaire F, Sidi D, Hartmann O. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer 2004;91:37-44.
4. Setser RM, Bexell DG, O'Donnell TP, Stillman AE, Lieber ML, Schoenhagen P, White RD. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 2003;18:434-41.
5. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105: 224-9.
6. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmermund A, Bruder O, Schuler WO, Barkhausen J. Myocardial late enhancement in contrast-enhanced cardiac CMR: distinction between infarction scar and non-infarction-related disease. AJR 2005;184: 1420-6.
7. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of CMR delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
8. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.